Evidence map›Paper›PMID 39118115›Full record

SynthesisBMC ophthalmology2024

Favorable outcome of Lasiodiplodia theobromae keratomycosis : a clinical case and systematic review.

Adam Lazrak, Nicole Desbois, Martin Bonnafous, Katia Ouamrane, Harold Merle

Abstract readSystematic ReviewCase Reports
In one paragraph

Synthesis in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Severe fungal keratitis caused byMedical mycology case reports · 2026
    Article
  2. Infection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adam LazrakDepartment of Ophthalmology, University Hospital Center of Martinique, Pierre Zobda-Quitman Hospital, BP 632, Fort de France Cedex, F-97261, France. adam.lazrak@chu-martinique.fr.
Nicole DesboisLaboratory of Mycology, University Hospital Center of Martinique, Pierre Zobda-Quitman Hospital, Fort de France, France.
Martin BonnafousDepartment of Ophthalmology, University Hospital Center of Martinique, Pierre Zobda-Quitman Hospital, BP 632, Fort de France Cedex, F-97261, France.
Katia OuamraneDepartment of Ophthalmology, University Hospital Center of Martinique, Pierre Zobda-Quitman Hospital, BP 632, Fort de France Cedex, F-97261, France.
Harold MerleDepartment of Ophthalmology, University Hospital Center of Martinique, Pierre Zobda-Quitman Hospital, BP 632, Fort de France Cedex, F-97261, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backroudKeratitis caused by Lasiodiplodia theobromae is rare and typically associated with a poor prognosis. Current literature lacks sufficient evidence on effective management of patients with this condition. CASE PRESENTATION: A 74-year-old former agricultural worker presented with a red right eye, discomfort, and decreased visual acuity, progressing over three days without treatment. Examination revealed type 2 diabetes and a non-perforating, spiculated corneal abscess with a hypopyon in the right eye. Initial treatment included a triple antibiotic therapy and supportive care. Direct mycological examination identified numerous septate mycelial filaments. Antifungal treatment with natamycin and voriconazole, both topically and orally, was initiated. Cultures confirmed Lasiodiplodia theobromae. The patient showed significant improvement. Treatment continued for eight weeks, with a final visual acuity of 20/50 due to a stromal scar.

conclusionAn extensive literature review conducted in November 2023, using databases such as PubMed and Google Scholar with the keywords "lasiodiplodia" and "keratitis" yielded no previous cases of this specific condition being managed solely with the combined use of natamycin and voriconazole. This antifungal combination is commonly included in most management protocols for fungal keratitis. Factors such as the use of corticosteroids and delayed diagnosis were noted to adversely affect the prognosis. This case and this systematic review underscores the potential for non-surgical management options in severe fungal keratitis.

Indexed as

Antifungal AgentsAscomycotaEye Infections, FungalAgedDrug Therapy, CombinationHumansKeratitisMaleNatamycinVisual AcuityVoriconazoleAntifungal AgentsNatamycinVoriconazoleFungal keratitisKeratomycosisLasiodiplodia theobromae

Identifiers

PMID39118115
PMCPMC11308431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.